Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree with your observation. That is why I didn't jump out a few weeks ago. But, with the recent sell off / nose dive in PPS and the recent self promotion unrelated to running BHRT by Tomas, I am questioning intentions & abilities of management.
Recovered?
Someone give me an example of a pharma stock that has recovered from the situation we appear to be in. I am long with BHRT. But I fear the clock is ticking down.
I agree, the utilization of Phase 4 trial does not have any impact on timing of Abbott in Canada. It does result in first hand prescribing, study, and experience by the leading ED practitioner in Canada. Ie. Smart move by Abbott, good move for Apricus
Thank you Hellsails,
A review of document provided no new insights. Although, this is the first time i have seen the pharmacokinetic properties. it demonstrated quite a dose dependent variability. This is likely due to the small number of patients in database.
With regard to 9 month shelf life vs. 12 month shelf life....unless bought by the truckload, I doubt it will stay on the shelf at home very long.
Dimitrios,
Can you copy and paste the whole thing n English?
Dimitrios,
I am unable to figure out how to translate to English. Any ideas?
Rvl
Hellsails
I would like to see report and have a crack at it.
I am a Doctor of Pharmacy & Pharmacist.
Could you provide link?
Thanks
I would rather the CEO of Bioheart make it a success. That is the job. Not self promotion
I am Sgt. Schultz....I know nothing
(other than what I read and is available to anyone else.)
However, now that you ask, Abbott / Abbvie has only a couple reasons to not forge ahead with Vitaros in Canada.
1. They don't believe there is profit. (Canada market is tiny for them) 2. They have a strategy that will compete with vitaros and tying Vitaros up in limbo. 3. They think they made a mistake with Vitaros, fired the person that did the deal and don't care anymore. 4. they have been distracted with the Abbott / Abbvie deal and may wake up soon, And 5. They are crafting much bigger deal for both Vitaros in remaining countries and Femprox worldwide OR buyout of Apricus Bio.
I personally like Number 4.
Anyone else have a plausible option?
Damaj is gone. Good riddance. Now let's discuss the present and future.
Will not open
Value
Well put, I am of the opinion every sexually active male will eventually use Vitaros sometime between the ages of 18 and death. It works rapidly and it has low incidence of side effects.
Unless management screws it up or there are individuals or corporations that are actively trying subterfuge the role out of a "great" product with worldwide appeal, Vitaros will be a huge success.
Eicoman
Thanks
Kingme,
Thanks for the find.
Where did you find this info?
Rvl
Just so they buy it
Disagree, if you were going to only bring out bring out clarification of accounting, it would have been after hours on Friday.
I think another hint that Monday will be good news is the fact it is scheduled BEFORE the market opens. You don't schedule bad news before market on a Monday.
Is that the one that bought 1.5 M shares one day and then sold 3.6 M shares 3 days later at a loss?
How much did Mr. Tomas invest of his own money?.
Where is this on their financial statement?
http://www.google.com/finance?q=OTCMKTS%3ABHRT&fstype=ii&ei=tKL1UeDZK6-00AHfQQ
Ditto
Dilution?
Stock dilution is a general term that results from the issue of additional common shares by a company. This increase in the number of shares outstanding can result from a primary market offering (including an initial public offering), employees exercising stock options, or by conversion of convertible bonds, preferred shares or warrants into stock. This dilution can shift fundamental positions of the stock such as ownership percentage, voting control, earnings per share, or the value of individual shares. A broader definition specifies dilution as any event that reduces an investor's stock price below the initial purchase price.
Very informative
Thanks DG
DG,
What are you thinking the answer to your question is?
"Now why would anybody think EU approval was a good time to drive the price down?"
RVL
$2.09 sale of 100 shares after hours. Gee, that is a legitimate, earnest trade.
Compared to YMB, the dialogue here is the word of God. If you think there conversation is not worth while, just go away. Based on your posts, you can only have one purpose for posting here. That is to confuse and dissuade those who have not figured out your motives.
By the way, same tactic on SNTA is being used
Under any circumstance, it's manipulation that is artificially setting something up for Monday that is not real so traders that are asleep at the switch will react in error.
RVL
Radar,
I am a pharmacologist by training. Not a professional investor.
I too keep buying on these artificial dips. The science of this product is compelling as proved again by EU decision. The question of whether or not Vitaros is safe and effective has been answered. The points Starbuck2 brings up about current market leaders, Viagra, Cialis, et.al. are true. Therefore, it's not a matter of "if" but a matter of "when" Vitaros sales begin to take off. Then, the larger money maker will be Femprox once studies have been completed and recognized. Unlike Vitaros, there is no real existing or impending threat to the market position Femprox will hold. Patience.
RVL
Yes, but if Lazard is true cause, it presents a GREAT buying opportunity
DG,
Thanks, very helpful.
Now I can sleep a little better.
Rick
What possible reason does Board member sell the same number of shares for the last few months?
2013-06-21
Sale 2013-06-21
9:26 pm APRICUS BIOSCIENCES, INC. APRI XANTHOPOULOS KLEANTHIS G
(Director) 2,864 $2.52 $7,217 72,919
(Indirect) View
Ok pedro, guess you invested above $18 to be able to lose any $. This stock has been nothing but up